Browse > Article
http://dx.doi.org/10.14480/JM.2021.19.3.115

Changes in gut microbiota with mushroom consumption  

Kim, Eui-Jin (Department of Biochemical Engineering, Chosun University)
Shin, Hyun-Jae (Department of Biochemical Engineering, Chosun University)
Publication Information
Journal of Mushroom / v.19, no.3, 2021 , pp. 115-125 More about this Journal
Abstract
Mushroom consumption causes changes in the immune system and gut microbiota via the actions of mushroom probiotic components. β-Glucan structure-related substances suppress secretion of inflammatory mediators, and induce macrophage activation, enhancing immunity and immune function. Substances other than directly useful components can be metabolized into short-chain fatty acids by gut microbiota. These short-chain fatty acids can then induce immunity, alleviating various diseases. Substances used to stimulate growth of health-promoting gut bacteria, thereby changing the gut microbiota community are defined to be probiotics. Probiotic altered intestinal microflora can prevent various types of bacterial infection from external sources, and can help to maintain immune system balance, thus preventing diseases. Research into beneficial components of Pleurotus eryngii, Lentinula edodes, Pleurotus ostreatus, Flammulina velutipes, Auricularia auricula-judae, and Agaricus bisporus, which are frequently consumed in Korea, changes in microbiota, changes in short-chain fatty acids, and correlations between consumption and health contribute to our understanding of the effects of dietary mushrooms on disease prevention and mitigation.
Keywords
Mushroom; Microbiota; Short chain fatty acid; ${\beta}$-glucan;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hagiwara, S.-y., M. Takahashi, Y. Shen, S. Kaihou, T. Tomiyama, M. Yazawa, Y. Tamai, Y. Sin, A. Kazusaka & M. Terazawa. 2005. A phytochemical in the edible Tamogi-take mushroom (Pleurotus cornucopiae), D-mannitol, inhibits ACE activity and lowers the blood pressure of spontaneously hypertensive rats. Bioscience, biotechnology, and biochemistry, 69: 1603-1605.   DOI
2 Ahmad, A., F. M. Anjum, T. Zahoor, H. Nawaz & S. M. R. Dilshad. 2012. Beta glucan: a valuable functional ingredient in foods. Critical reviews in food science and nutrition, 52: 201-212.   DOI
3 Ba, D. M., P. Ssentongo, R. B. Beelman, J. Muscat, X. Gao & J. P. Richie. 2021. Higher Mushroom consumption is associated with lower risk of cancer: a systematic review and meta-analysis of observational studies. Advances in Nutrition.
4 Bobek, P., E. Ginter, M. Jurcovicova & L. Kuniak. 1991. Cholesterol-lowering effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats. Annals of Nutrition and Metabolism, 35: 191-195.   DOI
5 Chen, J., J. Liu, C. Yan, C. Zhang, W. Pan, W. Zhang, Y. Lu, L. Chen & Y. Chen. 2020a. Sarcodon aspratus polysaccharides ameliorated obesity-induced metabolic disorders and modulated gut microbiota dysbiosis in mice fed a high-fat diet. Food & function, 11: 2588-2602.   DOI
6 Dubey, S. K., V. K. Chaturvedi, D. Mishra, A. Bajpeyee, A. Tiwari & M. Singh. 2019. Role of edible mushroom as a potent therapeutics for the diabetes and obesity. 3 Biotech, 9: 1-12.   DOI
7 Feng, H., S. Zhang, J. M.-F. Wan, L. Gui, M. Ruan, N. Li, H. Zhang, Z. Liu & H. Wang. 2018. Polysaccharides extracted from Phellinus linteus ameliorate high-fat high-fructose diet induced insulin resistance in mice. Carbohydrate polymers, 200: 144-153.   DOI
8 Hyder, M. S. & S. D. Dutta. 2021. Mushroom-derived polysaccharides as antitumor and anticancer agent: A concise review. Biocatalysis and Agricultural Biotechnology, 102085.
9 Chang, C.-J., C.-S. Lin, C.-C. Lu, J. Martel, Y.-F. Ko, D. M. Ojcius, S.-F. Tseng, T.-R. Wu, Y.-Y. M. Chen & J. D. Young. 2015. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature communications, 6: 1-19.
10 Chen, L., L. Zhang, W. Wang, W. Qiu, L. Liu, A. Ning, J. Cao, M. Huang & M. Zhong .2020b. Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet. PloS one, 15: e0232972.   DOI
11 Lakhanpal, T. & M. Rana. 2005. Medicinal and nutraceutical genetic resources of mushrooms. Plant Genetic Resources, 3: 288-303.   DOI
12 Zhang, J., X. Yu, B. Xu, A. E. A. Yagoub, A. T. Mustapha & C. Zhou. 2021. Effect of intensive pulsed light on the activity, structure, physico-chemical properties and surface topography of polyphenol oxidase from mushroom. Innovative Food Science & Emerging Technologies, 102741.
13 Harrington, V., L. Lau, K. Seddu & J. Suez. 2021. Ecology and Medicine Converge at the Microbiome-Host Interface. Msystems, 6: e00756-21.
14 Sasaki, H., T. Ishizuka, M. Muto, M. Nezu, Y. Nakanishi, Y. Inagaki, H. Watanabe, H. Watanabe & M. Terada. 1998. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer research, 58: 2991-2995.
15 Wu, T.-R., C.-S. Lin, C.-J. Chang, T.-L. Lin, J. Martel, Y.-F. Ko, D. M. Ojcius, C.-C. Lu, J. D. Young & H.-C. Lai. 2019. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut, 68: 248-262.   DOI
16 Chen, Y., D. Liu, D. Wang, S. Lai, R. Zhong, Y. Liu, C. Yang, B. Liu, M. R. Sarker & C. Zhao. 2019. Hypoglycemic activity and gut microbiota regulation of a novel polysaccharide from Grifola frondosa in type 2 diabetic mice. Food and Chemical Toxicology, 126: 295-302.   DOI
17 Kallus, S. J. & L. J. Brandt. 2012. The intestinal microbiota and obesity. Journal of clinical gastroenterology, 46: 16-24.   DOI
18 Kim, G.-Y., G.-S. Choi, S.-H. Lee & Y.-M. Park. 2004. Acidic polysaccharide isolated from Phellinus linteus enhances through the up-regulation of nitric oxide and tumor necrosis factor-α from peritoneal macrophages. Journal of Ethnopharmacology, 95: 69-76.   DOI
19 Li, X., F. Zeng, Y. Huang & B. Liu. 2019b. The positive effects of Grifola frondosa heteropolysaccharide on NAFLD and regulation of the gut microbiota. International journal of molecular sciences, 20: 5302.   DOI
20 Liu, Y., C. Wang, J. Li, T. Li, Y. Zhang, Y. Liang & Y. Mei. 2020. Phellinus linteus polysaccharide extract improves insulin resistance by regulating gut microbiota composition. The FASEB Journal, 34: 1065-1078.   DOI
21 Lv, X.-C., W.-L. Guo, L. Li, X.-D. Yu & B. Liu. 2019. Polysaccharide peptides from Ganoderma lucidum ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet-fed rats. Journal of Functional Foods, 57: 48-58.   DOI
22 John, G. K. & G. E. Mullin. 2016. The gut microbiome and obesity. Current oncology reports, 18: 1-7.   DOI
23 Lee, J. E., S. Lee, H. Lee, Y.-M. Song, K. Lee, M. J. Han, J. Sung & G. Ko. 2013. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PloS one, 8: e63514.   DOI
24 Zhao, S., Q. Gao, C. Rong, S. Wang, Z. Zhao, Y. Liu & J. Xu. 2020. Immunomodulatory effects of edible and medicinal mushrooms and their bioactive immunoregulatory products. Journal of Fungi, 6: 269.   DOI
25 Guo, W.-L., J.-C. Deng, Y.-Y. Pan, J.-X. Xu, J.-L. Hong, F.-F. Shi, G.-L. Liu, M. Qian, W.-D. Bai & W. Zhang. 2020. Hypoglycemic and hypolipidemic activities of Grifola frondosa polysaccharides and their relationships with the modulation of intestinal microflora in diabetic mice induced by high-fat diet and streptozotocin. International journal of biological macromolecules, 153: 1231-1240.   DOI
26 Jesenak, M., J. Majtan, Z. Rennerova, J. Kyselovic, P. Banovcin & M. Hrubisko. 2013. Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections. International Immunopharmacology, 15: 395-399.   DOI
27 Chen, M., D. Xiao, W. Liu, Y. Song, B. Zou, L. Li, P. Li, Y. Cai, D. Liu & Q. Liao. 2020c. Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats. International journal of biological macromolecules, 155: 890-902.   DOI
28 Davies, C., D. Mishra, R. S. Eshraghi, J. Mittal, R. Sinha, E. Bulut, R. Mittal & A. A. Eshraghi. 2021. Altering the gut microbiome to potentially modulate behavioral manifestations in autism spectrum disorders: A systematic review. Neuroscience & Biobehavioral Reviews, 128: 549-557.   DOI
29 Diamandis, E. P. 2014. Present and future of cancer biomarkers. Clinical Chemistry and Laboratory Medicine (CCLM), 52: 791-794.   DOI
30 Khatun, K., H. Mahtab, P. Khanam, M. Sayeed & K. Khan. 2007. Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh medical journal: MMJ, 16: 94-99.
31 Lin, J.-Y., T.-W. Jeng, C.-C. Chen, G.-Y. Shi & T.-C. Tung. 1973. Isolation of a new cardiotoxic protein from the edible mushroom, Volvariella volvacea. Nature, 246: 524-525.   DOI
32 Ma, G., H. Du, Q. Hu, W. Yang, F. Pei & H. Xiao. 2021. Health benefits of edible mushroom polysaccharides and associated gut microbiota regulation. Critical Reviews in Food Science and Nutrition, 1-18.
33 Mariat, D., O. Firmesse, F. Levenez, V. Guimaraes, H. Sokol, J. Dore, G. Corthier & J. Furet. 2009. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC microbiology, 9: 1-6.   DOI
34 Park, J. W., H. Y. Kim, M. G. Kim, S. Jeong, C.-H. Yun & S. H. Han. 2019. Short-chain fatty acids inhibit staphylococcal lipoprotein-induced nitric oxide production in murine macrophages. Immune network, 19.
35 Harshavardhini, B. & P. D. Sharma. 2021. Drying Characteristics of Button Mushroom. Int. J. Curr. Microbiol. App. Sci, 10: 503-512.   DOI
36 Ooi, V. E. C. & F. Liu. 1999. A review of pharmacological activities of mushroom polysaccharides. International Journal of medicinal mushrooms, 1.
37 Muthuramalingam, K., V. Singh, C. Choi, S. I. Choi, S. Park, Y. M. Kim, T. Unno & M. Cho. 2019. Effect of mushroom (Schizophyllum spp.) derived β-glucan on low-fiber diet induced gut dysbiosis. Journal of Applied Biological Chemistry, 62: 211-217.   DOI
38 Nichols, R. G. & E. R. Davenport. 2021. The relationship between the gut microbiome and host gene expression: a review. Human genetics, 140: 747-760.   DOI
39 Ohno, N., S. Nameda, T. Harada, N. N. Miura, Y. Adachi, M. Nakajima, K. Yoshida, H. Yoshida & T. Yadomae. 2003. Immunomodulating Activity of a b-Glucan Preparation, SCG, Extracted from a Culinary-Medicinal Mushroom, Sparassis crispa Wulf.: Fr.(Aphyllophoromycetideae), and Application to Cancer Patients. International Journal of Medicinal Mushrooms, 5.
40 Narikiyo, M., C. Tanabe, Y. Yamada, H. Igaki, Y. Tachimori, H. Kato, M. Muto, R. Montesano, H. Sakamoto & Y. Nakajima. 2004. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer science, 95: 569-574.   DOI
41 Tong, A. J., R. K. Hu, L. X. Wu, X. C. Lv, X. Li, L. N. Zhao & B. Liu. 2020. Ganoderma polysaccharide and chitosan synergistically ameliorate lipid metabolic disorders and modulate gut microbiota composition in high fat diet-fed golden hamsters. Journal of food biochemistry, 44: e13109.
42 Fang, J., Y. Wang, X. Lv, X. Shen, X. Ni & K. Ding. 2012. Structure of a β-glucan from Grifola frondosa and its antitumor effect by activating Dectin-1/Syk/NF-κB signaling. Glycoconjugate journal, 29: 365-377.   DOI
43 Grivennikov, S. I., K. Wang, D. Mucida, C. A. Stewart, B. Schnabl, D. Jauch, K. Taniguchi, G.-Y. Yu, C. H. Osterreicher & K. E. Hung. 2012. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature, 491: 254-258.   DOI
44 Alves, M. J., I. C. Ferreira, J. Dias, V. Teixeira, A. Martins & M. Pintado. 2012. A review on antimicrobial activity of mushroom (Basidiomycetes) extracts and isolated compounds. Planta medica, 78: 1707-1718.   DOI
45 Anderson, L. A., S. J. Murphy, B. T. Johnston, R. Watson, H. Ferguson, K. B. Bamford, A. Ghazy, P. McCarron, J. McGuigan & J. V. Reynolds. 2008. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut, 57: 734-739.   DOI
46 Fernandez-Julia, P., J. Munoz-Munoz & D. van Sinderen. 2021. A comprehensive review on the impact of β-glucan metabolism by Bacteroides and Bifidobacterium species as members of the gut microbiota. International Journal of Biological Macromolecules.
47 Guo, X., X. Xia, R. Tang, J. Zhou, H. Zhao & K. Wang. 2008. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Letters in applied microbiology, 47: 367-373.   DOI
48 Farrell, J. J., L. Zhang, H. Zhou, D. Chia, D. Elashoff, D. Akin, B. J. Paster, K. Joshipura & D. T. Wong. 2012. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut, 61: 582-588.   DOI
49 BHAT, Z. A., A. H. WANI, J. M. WAR & M. Y. BHAT. 2021. MAJOR BIOACTIVE PROPERTIES OF GANODERMA POLYSACCHARIDES: A REVIEW. Asian J Pharm Clin Res, 14: 11-24.
50 Barea-Sepulveda, M., E. Espada-Bellido, M. Ferreiro-Gonzalez, A. Benitez-Rodriguez, J. G. Lopez-Castillo, M. Palma & G. F. Barbero. 2021. Metal concentrations in Lactarius mushroom species collected from Southern Spain and Northern Morocco: Evaluation of health risks and benefits. Journal of Food Composition and Analysis, 99: 103859.   DOI
51 Macfarlane, S., E. Furrie, G. T. Macfarlane & J. F. Dillon. 2007. Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clinical infectious diseases, 45: 29-38.   DOI
52 Mager, D., A. Haffajee, P. Devlin, C. Norris, M. Posner & J. Goodson. 2005. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. Journal of translational medicine, 3: 1-8.   DOI
53 Mishra, R. R., M. Tewari & H. S. Shukla. 2011. Helicobacter pylori and pathogenesis of gallbladder cancer. Journal of gastroenterology and hepatology, 26: 260-266.   DOI
54 Muller, L. B., R. B. Fagundes, C. C. d. Moraes & A. Rampazzo. 2007. Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia. Arquivos de gastroenterologia, 44: 93-98.   DOI
55 Nakahara, D., C. Nan, K. Mori, M. Hanayama, H. Kikuchi, S. Hirai & Y. Egashira. 2020. Effect of mushroom polysaccharides from Pleurotus eryngii on obesity and gut microbiota in mice fed a high-fat diet. European journal of nutrition, 59: 3231-3244.   DOI
56 Yin, C., G. D. Noratto, X. Fan, Z. Chen, F. Yao, D. Shi & H. Gao. 2020. The impact of mushroom polysaccharides on gut microbiota and its beneficial effects to host: A review. Carbohydrate Polymers, 116942.   DOI
57 Nowakowski, P., R. Markiewicz-Zukowska, J. Bielecka, K. Mielcarek, M. Grabia & K. Socha. 2021. Treasures from the forest: Evaluation of mushroom extracts as anti-cancer agents. Biomedicine & Pharmacotherapy, 143: 112106.   DOI
58 Pan, Y., X. Wan, F. Zeng, R. Zhong, W. Guo, X.-C. Lv, C. Zhao & B. Liu. 2020. Regulatory effect of Grifola frondosa extract rich in polysaccharides and organic acids on glycolipid metabolism and gut microbiota in rats. International journal of biological macromolecules, 155: 1030-1039.   DOI
59 Nitschke, J., H. Modick, E. Busch, R. W. Von Rekowski, H.-J. Altenbach & H. Molleken. 2011. A new colorimetric method to quantify β-1, 3-1, 6-glucans in comparison with total β-1, 3-glucans in edible mushrooms. Food chemistry, 127: 791-796.   DOI
60 Ser, H.-L., V. Letchumanan, B.-H. Goh, S. H. Wong & L.-H. Lee. 2021.The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Frontiers in Microbiology, 12: 1005.
61 Seo, D. J. & C. Choi. 2021. Antiviral bioactive compounds of mushrooms and their antiviral mechanisms: a review. Viruses, 13: 350.   DOI
62 Usman, M., G. Murtaza & A. Ditta. 2021. Nutritional, Medicinal, and Cosmetic Value of Bioactive Compounds in Button Mushroom (Agaricus bisporus): A Review. Applied Sciences, 11: 5943.   DOI
63 Wasser, S. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied microbiology and biotechnology, 60: 258-274.   DOI
64 Wasser, S. P. & A. L. Weis. 1999. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives. International Journal of medicinal mushrooms, 1.
65 Schmitt, M., C. Depuydt, I. Benoy, J. Bogers, J. Antoine, M. Pawlita & M. Arbyn. 2013b. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions. Cancer Epidemiology and Prevention Biomarkers, 22: 406-414.   DOI
66 Priyadarshini, M., K. Lednovich, K. Xu, S. Gough, B. Wicksteed & B. T. Layden. 2021. FFAR from the Gut Microbiome Crowd: SCFA Receptors in T1D Pathology. Metabolites, 11: 302.   DOI
67 Sasaki, M., C. Yamaura, Y. Ohara-Nemoto, S. Tajika, Y. Kodama, T. Ohya, R. Harada & S. Kimura. 2005. Streptococcus anginosus infection in oral cancer and its infection route. Oral diseases, 11: 151-156.   DOI
68 Schmitt, M., C. Depuydt, I. Benoy, J. Bogers, J. Antoine, M. Arbyn, M. Pawlita & V. S. Group. 2013a. Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. International journal of cancer, 132: 2395-2403.   DOI
69 Sharma, V., V. S. Chauhan, G. Nath, A. Kumar & V. K. Shukla. 2007. Role of bile bacteria in gallbladder carcinoma. Hepatogastroenterology, 54: 1622-1625.
70 Shen, X. J., J. F. Rawls, T. A. Randall, L. Burcall, C. Mpande, N. Jenkins, B. Jovov, Z. Abdo, R. S. Sandler & T. O. Keku. 2010. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut microbes, 1: 138-147.   DOI
71 Li, L., W.-L. Guo, W. Zhang, J.-X. Xu, M. Qian, W.-D. Bai, Y.-Y. Zhang, P.-F. Rao, L. Ni & X.-C. Lv. 2019a. Grifola frondosa polysaccharides ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet fed rats. Food & function, 10: 2560-2572.   DOI
72 Xu, S., Y. Dou, B. Ye, Q. Wu, Y. Wang, M. Hu, F. Ma, X. Rong & J. Guo. 2017. Ganoderma lucidum polysaccharides improve insulin sensitivity by regulating inflammatory cytokines and gut microbiota composition in mice. Journal of Functional Foods, 38: 545-552.   DOI
73 Xu, Y., M. Shen, Y. Chen, Y. Lou, R. Luo, J. Chen, Y. Zhang, J. Li & W. Wang. 2018. Optimization of the polysaccharide hydrolysate from Auricularia auricula with antioxidant activity by response surface methodology. International journal of biological macromolecules, 113: 543-549.   DOI
74 Chakraborty, N., A. Banerjee, A. Sarkar, S. Ghosh & K. Acharya . 2021. Mushroom polysaccharides: A potent immunemodulator. Biointerface Research in Applied Chemistry, 11: 8915-8930.   DOI
75 Vaishampayan, P. A., J. V. Kuehl, J. L. Froula, J. L. Morgan, H. Ochman & M. P. Francino. 2010. Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome biology and evolution, 2: 53-66.   DOI
76 Shan-Shan, S., W. Kai, M. Ke, B. Li & L. Hong-Wei. 2019. An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota. Chinese journal of natural medicines, 17: 3-14.   DOI
77 Sobhani, I., J. Tap, F. Roudot-Thoraval, J. P. Roperch, S. Letulle, P. Langella, G. Corthier, J. T. Van Nhieu & J. P. Furet. 2011. Microbial dysbiosis in colorectal cancer (CRC) patients. PloS one, 6: e16393.   DOI
78 Swidsinski, A., M. Khilkin, D. Kerjaschki, S. Schreiber, M. Ortner, J. Weber & H. Lochs. 1998. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology, 115: 281-286.   DOI
79 Zhang, P. & P. C. Cheung. 2002. Evaluation of sulfated Lentinus edodes α-(1→3)-d-glucan as a potential antitumor agent. Bioscience, biotechnology, and biochemistry, 66: 1052-1056.   DOI
80 Yamanaka, D., M. Shoda, T. Matsubara, K.-i. Ishibashi, A. Motoi, R. Motoi, M. Motoi, N. Ohno & Y. Adachi. 2021. Open-Label Study of the Influence of Food Containing the Royal Sun Mushroom, Agaricus brasiliensis KA21 (Agaricomycetes), on β-Glucan-Specific Antibody Production in Healthy Human Volunteers. International Journal of Medicinal Mushrooms, 23.
81 Patel, D. K., S. D. Dutta, K. Ganguly, S.-J. Cho & K.-T. Lim. 2021. Mushroom-derived bioactive molecules as immunotherapeutic agents: A review. Molecules, 26: 1359.   DOI
82 Stojanov, S., A. Berlec & B. Strukelj. 2020. The influence of probiotics on the Firmicutes/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms, 8: 1715.   DOI
83 Sun, S., Y. Yang, X. Lin, P. Chen, L. Ye, L. Zeng, Q. Ye, X. Yang, J. Ceng & J. Shan. 2021. Qiweibaizhu Decoction Treats Diarrheal Juvenile Rats by Modulating the Gut Microbiota, Short-Chain Fatty Acids, and the Mucus Barrier. Evidence-Based Complementary and Alternative Medicine, 2021.